President of Mirai Bio, a Flagship-founded company unveiled in 2024, Jens Vogel describes how the company is advancing the delivery of genetic medicines and why Mirai is positioned to work with partners across biotech and pharma looking to optimize performance and accelerate development of any genetic medicine. More from Flagship @ JPM2025 here.
Related Companies
- Mirai Bio Founded: 2021
